Greg Licholai is a multi-disciplinary health-care strategist, physician and executive who uniquely bridges medicine, business and biotechnology. He holds an MD and MBA, has taught innovation and health-care strategy at Yale School of Management and Harvard Business School, and serves as Chief Medical & Innovation Officer at ICON plc, a major contract research organization supporting clinical trials.